Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
HIK | London | GBP | Real-time | |
HIKl | BATS Europe | GBP | Delayed | |
HKMPY | OTC Markets | USD | Delayed | |
HIK | Frankfurt | EUR | Delayed |
Hikma Pharmaceuticals (OTC:HKMPY) PLC (HIK.L), a global pharmaceutical company, reported a robust performance for the fiscal year 2023, with significant growth in revenue and core...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Neutral | Buy | Neutral | Strong Sell | Sell |
Technical Indicators | Sell | Strong Buy | Strong Buy | Strong Sell | Strong Sell |
Summary | Neutral | Strong Buy | Buy | Strong Sell | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Bullish doji Star | 1W | Current | |||
Completed Patterns | |||||
Three Inside Up | 1M | 3 | Jan 24 | ||
Bullish Engulfing | 1W | 4 | Mar 17, 2024 | ||
Bullish doji Star | 1W | 5 | Mar 10, 2024 |
Exchange | Last | Bid | Ask | Volume | Change % | Currency | Time | ||
---|---|---|---|---|---|---|---|---|---|
London | 1,789.00 | 1,750.00 | 2,222.00 | 968,551 | +0.85% | GBP | |||
BATS Europe | 1,789.00 | 0.00 | 0.00 | 72,496 | +0.06% | GBP | |||
OTC Markets | 46.5 | 0.0 | 0.0 | 247 | 0.00% | USD | |||
Frankfurt | 20.600 | 21.000 | 21.200 | 0 | -0.96% | EUR |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IAG | 169.80 | 187.90 | 163.55 | +9.10 | +5.66% | 35.30M | |||
Rolls-Royce Holdings | 402.50 | 406.71 | 398.30 | +1.10 | +0.27% | 34.65M | |||
EasyJet | 530.00 | 547.00 | 526.40 | +11.80 | +2.28% | 15.43M | |||
Lloyds Banking | 51.00 | 51.30 | 50.62 | +0.58 | +1.15% | 95.48M | 18/04 | ||
BP | 512.40 | 515.10 | 508.20 | -4.40 | -0.85% | 36.63M | 18/04 | ||
Ocado | 350.00 | 350.50 | 3.48 | +1.80 | +0.52% | 3.54M | |||
Centamin | 128.10 | 129.50 | 120.10 | -1.60 | -1.23% | 10.66M | |||
Barclays | 183.98 | 183.98 | 181.14 | +4.04 | +2.25% | 72.90M | 18/04 | ||
HSBC | 644.60 | 645.60 | 637.60 | +8.50 | +1.34% | 44.84M | 18/04 | ||
BAE Systems | 1,287.00 | 1,316.50 | 1,272.50 | -33.00 | -2.50% | 11.50M | 18/04 |
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review